SG11201505590TA - An antiviral pharmaceutical composition - Google Patents
An antiviral pharmaceutical compositionInfo
- Publication number
- SG11201505590TA SG11201505590TA SG11201505590TA SG11201505590TA SG11201505590TA SG 11201505590T A SG11201505590T A SG 11201505590TA SG 11201505590T A SG11201505590T A SG 11201505590TA SG 11201505590T A SG11201505590T A SG 11201505590TA SG 11201505590T A SG11201505590T A SG 11201505590TA
- Authority
- SG
- Singapore
- Prior art keywords
- pharmaceutical composition
- antiviral pharmaceutical
- antiviral
- composition
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI2013700109A MY169312A (en) | 2013-01-17 | 2013-01-17 | An antiviral pharmaceutical composition |
PCT/MY2014/000004 WO2014112861A1 (en) | 2013-01-17 | 2014-01-08 | An antiviral pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201505590TA true SG11201505590TA (en) | 2015-08-28 |
Family
ID=51209875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201505590TA SG11201505590TA (en) | 2013-01-17 | 2014-01-08 | An antiviral pharmaceutical composition |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU2014207946A1 (en) |
MY (1) | MY169312A (en) |
SG (1) | SG11201505590TA (en) |
WO (1) | WO2014112861A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106692127B (en) * | 2016-12-12 | 2021-01-15 | 东莞广州中医药大学中医药数理工程研究院 | Application of luteolin in preparation of medicine for preventing and treating dengue fever virus infection |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7605135B2 (en) * | 2003-11-10 | 2009-10-20 | The University Of Hong Kong | Baicalin as a treatment for SARS infection |
WO2009097512A1 (en) * | 2008-02-01 | 2009-08-06 | Innovative Drug Discovery Inc. | Herbal pharmaceutical compositions to treat inflammation and inflammation associated conditions and diseases |
MY151083A (en) * | 2012-03-30 | 2014-04-04 | Univ Malaya | Antiviral composition against flavivirus |
-
2013
- 2013-01-17 MY MYPI2013700109A patent/MY169312A/en unknown
-
2014
- 2014-01-08 AU AU2014207946A patent/AU2014207946A1/en not_active Abandoned
- 2014-01-08 SG SG11201505590TA patent/SG11201505590TA/en unknown
- 2014-01-08 WO PCT/MY2014/000004 patent/WO2014112861A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
AU2014207946A1 (en) | 2015-08-06 |
WO2014112861A1 (en) | 2014-07-24 |
MY169312A (en) | 2019-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL288961A (en) | Pharmaceutical compositions | |
HK1225716A1 (en) | Antiviral compounds | |
PL3030262T3 (en) | Combined pharmaceutical composition | |
PL2943181T3 (en) | Pharmaceutical compositions | |
HK1216885A1 (en) | Antiviral compounds | |
PL3043778T3 (en) | Pharmaceutical compositions containing refametinib | |
ZA201408333B (en) | Pharmaceutical compositions | |
EP2990038A4 (en) | Solid pharmaceutical composition | |
HK1217943A1 (en) | Antiviral compounds | |
SG11201601477VA (en) | Pharmaceutical composition | |
SG11201509194SA (en) | Radiomitigating pharmaceutical formulations | |
HRP20171888T1 (en) | Pharmaceutical compositions | |
HUP1300496A2 (en) | Stable pharmaceutical composition | |
HK1220143A1 (en) | Pharmaceutical composition | |
ZA201509091B (en) | Antivirally effective pharmaceutical composition | |
EP2950789A4 (en) | Antiviral compounds | |
SG11201505590TA (en) | An antiviral pharmaceutical composition | |
HK1217200A1 (en) | Antiviral compounds | |
HK1216884A1 (en) | Antiviral compounds | |
GB201304699D0 (en) | Pharmaceutical compositions | |
GB201321497D0 (en) | Pharmaceutical compositions | |
GB201312851D0 (en) | Pharmaceutical compositions | |
GB201316662D0 (en) | Pharmaceutical Combination | |
GB201311373D0 (en) | Antiviral drug derivatives | |
GB201311374D0 (en) | Antiviral Drug Derivatives |